TY - GEN AU - Ponticelli,C AU - Yussim,A AU - Cambi,V AU - Legendre,C AU - Rizzo,G AU - Salvadori,M AU - Kahn,D AU - Kashi,S H AU - Salmela,K AU - Fricke,L AU - Garcia-Martinez,J AU - Lechler,R AU - Heemann,U AU - Monteon,F AU - Ortuño,J AU - Amenabar,J J AU - Arias,M AU - Nicholson,M L AU - Sperschneider,H AU - Abendroth,D AU - Gracida,C AU - Lao,M AU - Sever,M S AU - Lameire,N AU - Sanchez-Fructuoso,A AU - Bascì,A AU - Segoloni,G AU - Connolly,J AU - Altieri,P AU - Akoh,J AU - Prestele,H AU - Girault,D TI - Basiliximab significantly reduces acute rejection in renal transplant patients given triple therapy with azathioprine SN - 0041-1345 PY - 2001///0628 KW - Acute Disease KW - Adolescent KW - Adult KW - Aged KW - Anti-Inflammatory Agents KW - therapeutic use KW - Antibodies, Monoclonal KW - Azathioprine KW - Basiliximab KW - Cyclosporine KW - Drug Therapy, Combination KW - Female KW - Graft Rejection KW - Humans KW - Immunosuppressive Agents KW - Infections KW - etiology KW - Kidney Transplantation KW - immunology KW - Male KW - Middle Aged KW - Postoperative Complications KW - Prednisone KW - Recombinant Fusion Proteins N1 - Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial UR - https://doi.org/10.1016/s0041-1345(00)02307-1 ER -